Original Research
Accepted on 04 Mar 2026
Cost-Effectiveness of Treatment Sequences Following First-Line Rituximab in Relapsing-Remitting Multiple Sclerosis: A Norwegian Microsimulation Study
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 04 Mar 2026
in Multiple Sclerosis and Neuroimmunology
Retraction
Accepted on 04 Mar 2026
in Alzheimer's Disease and Related Dementias
Retraction
Accepted on 04 Mar 2026
in Alzheimer's Disease and Related Dementias
Original Research
Accepted on 04 Mar 2026
in Plant Systematics and Evolution
Original Research
Accepted on 04 Mar 2026
in Gynecological Oncology
Perspective
Accepted on 04 Mar 2026
in Behavioral and Psychiatric Genetics
Brief Research Report
Accepted on 04 Mar 2026
in Stroke
Original Research
Accepted on 04 Mar 2026
in Thyroid Endocrinology
Original Research
Accepted on 04 Mar 2026
in Photosynthesis and Photobiology
Original Research
Accepted on 04 Mar 2026
in Sleep Disorders
Original Research
Accepted on 04 Mar 2026
in Gastroenterology
Systematic Review
Accepted on 04 Mar 2026
in Stroke
Original Research
Accepted on 04 Mar 2026
in Adolescent and Young Adult Psychiatry
Original Research
Accepted on 04 Mar 2026
in Disease and Health Management
Original Research
Accepted on 04 Mar 2026
in Thoracic Oncology
Original Research
Accepted on 04 Mar 2026
in Fluid Dynamics